Other OTC - Delayed Quote USD

Hemogenyx Pharmaceuticals Plc (HOPHF)

0.0400 0.0000 (0.00%)
At close: January 26 at 1:57 PM EST
Advanced Chart
Loading Chart for HOPHF
DELL
  • Previous Close 0.0400
  • Open 0.0400
  • Bid --
  • Ask --
  • Day's Range 0.0400 - 0.0400
  • 52 Week Range 0.0400 - 0.2000
  • Volume 125,000
  • Avg. Volume 1,984
  • Market Cap (intraday) 53.673M
  • Beta (5Y Monthly) 3.03
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood diseases. It is involved in developing products for bone marrow/hematopoietic stem cell (BM/HSC) transplant market, including CDX bi-specific antibody targeting relapsed/refractory acute myeloid leukaemia (R/R AML); HEMO-CAR-T therapy, a chimeric antigen receptor T-cells to identify and destroy human AML-derived cells in vitro and in vivo; and Human Postnatal Hematopoietic Endothelial Cells, a stem cell therapy product for BM/HSC transplants. The company was founded in 2012 and is headquartered in London, the United Kingdom.

www.hemogenyx.com

14

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

More about Hemogenyx Pharmaceuticals Plc

Recent News: HOPHF

View More
View More

Performance Overview: HOPHF

Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

HOPHF
0.00%
FTSE 100
4.79%

1-Year Return

HOPHF
0.00%
FTSE 100
2.42%

3-Year Return

HOPHF
63.64%
FTSE 100
16.79%

5-Year Return

HOPHF
--
FTSE 100
19.98%

Compare To: HOPHF

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

HOPHF
Hemogenyx Pharmaceuticals Plc
0.0400
0.00%
Mkt Cap 53.673M
Industry Biotechnology
ENSC
Ensysce Biosciences, Inc.
0.5586
-1.48%
Mkt Cap 4.237M
Industry Biotechnology
ANNX
Annexon, Inc.
4.4500
+0.23%
Mkt Cap 400.614M
Industry Biotechnology
AKBA
Akebia Therapeutics, Inc.
1.3700
0.00%
Mkt Cap 286.84M
Industry Biotechnology
VKTX
Viking Therapeutics, Inc.
65.07
+0.22%
Mkt Cap 7.172B
Industry Biotechnology
NVO
Novo Nordisk A/S
126.16
-1.93%
Mkt Cap 562.841B
Industry Biotechnology

Statistics: HOPHF

View More

Valuation Measures

Annual
As of 4/24/2024

  • Market Cap

    26.87M

  • Enterprise Value

    27.09M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    11.86

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    -4.40

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -58.66%

  • Return on Equity (ttm)

    -136.44%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -7.17M

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.08M

  • Total Debt/Equity (mrq)

    89.95%

  • Levered Free Cash Flow (ttm)

    -4.48M

View More

Company Insights: HOPHF